Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.470EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.470EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.31 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.31 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.51 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.51 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.5 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.122.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.40.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.403EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.636EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.636EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.126EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.126EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDQ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBLEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.466.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.222EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.402EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.609EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.609EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.344EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.556EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used